Author Information
David B. Weiner is a prominent figure in the field of nanotechnology and biotechnology, currently affiliated with the Department of Pathology at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. His extensive research focuses on the delivery of nucleic acids and the development of DNA vaccines, which have significant implications in immunotherapy and infectious diseases.
Research Contributions
David B. Weiner has made substantial contributions to the field of immunotherapy and vaccine development, particularly in the context of SARS-CoV-2 and other viral infections. His work has explored the effectiveness of DNA vaccines, synthetic DNA delivery, and immunotherapy targeting various pathogens and cancer. In 2022 alone, he has published multiple papers on SARS-CoV-2 DNA vaccines, HIV vaccine development, and anti-tumor responses against Epstein-Barr-virus-associated carcinomas. His research is characterized by a focus on rapid and potent immunogenicity capable of providing robust protection, often through single-dose administration.
Aliases
David B. Weiner is also known by several aliases, including Davidb . Weiner, David b. Weiner, David Weiner, D Weiner, David B Weiner, D B Weiner, D. Weiner, D.b. Weiner, Davi B Weiner, David B. Weiner, and D. B. Weiner.
Publication and Citation Metrics
| Metric |
Value |
| Citation Count |
26,915 |
| h-index |
83 |
| Paper Count |
679 |
